60 Degrees Pharmaceuticals (SXTP) Notes Payables (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Notes Payables of $379308.0 for Q1 2026, down 40.33% year-over-year from $635725.0 in Q1 2025, and up 1.22% quarter-over-quarter from $374741.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Notes Payables (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Notes Payables for 5 consecutive years, with $379308.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables fell 40.33% year-over-year to $379308.0; the TTM figure through Mar 2026 stood at $379308.0 (down 40.33% YoY), while the FY2025 annual figure was $374741.0, down 41.52% from the prior year.
- Notes Payables improved to $379308.0 in Q1 2026 per SXTP's latest filing, from $374741.0 in the prior quarter.
- Across five years, Notes Payables topped out at $2.3 million in Q4 2023 and bottomed at $374741.0 in Q4 2025.
- Historically, Notes Payables has averaged $886545.2 across 5 years, with a median of $635725.0 in 2025.
- Annual changes were most pronounced in 2023 — Notes Payables soared 298.99% — and 2024, when it plunged 72.22%.
- 60 Degrees Pharmaceuticals' Notes Payables stood at $578164.0 in 2022, then jumped by 298.99% to $2.3 million in 2023, then slumped by 72.22% to $640830.0 in 2024, then plunged by 41.52% to $374741.0 in 2025, then advanced by 1.22% to $379308.0 in 2026.
- Business Quant data shows SXTP's Notes Payables at $379308.0 in Q1 2026, $374741.0 in Q4 2025, and $797275.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 379,308.00 |
| Dec 31, 2025 | 374,741.00 |
| Sep 30, 2025 | 797,275.00 |
| Jun 30, 2025 | 776,172.00 |
| Mar 31, 2025 | 635,725.00 |
| Dec 31, 2024 | 640,830.00 |
| Sep 30, 2024 | 623,762.00 |
| Jun 30, 2024 | 567,050.00 |
| Mar 31, 2024 | 565,949.00 |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Dec 31, 2022 | 578,164.00 |